Skip to main content
. Author manuscript; available in PMC: 2023 Oct 5.
Published in final edited form as: Vaccine. 2016 Apr 13;34(22):2519–2526. doi: 10.1016/j.vaccine.2016.03.027

Table 3.

Immune response after bOPV vaccination, by participant characteristics.

Type 1 Poliovirus (N = 320)
Type 3 Poliovirus (N = 445)
Total n % Responding (95% CI)a p-Valueb Total n % Responding (95% CI) p-Valueb
Age <0.001 <0.001
6 weeks to 3 months 158 73 (66, 80) 180 53 (46, 60)
3–6 months 115 56 (46, 64) 176 41 (34, 48)
6–12 months 47 36 (24, 50) 89 27 (19, 37)
Sex 0.816 0.771
Male 187 61 (54, 68) 261 42 (37, 49)
Female 133 62 (54, 70) 184 44 (37, 51)
Mother’s education 0.568 0.847
Less than primary school 168 59 (51, 67) 236 42 (36, 48)
Completed primary or some secondary 58 66 (53, 76) 80 45 (35, 56)
Completed secondary or higher 93 64 (54, 73) 128 44 (36, 53)
Facility 0.010 <0.001
BPKIHS 83 64 (53, 73) 116 50 (41, 59)
Kanti 56 79 (66, 87) 80 62 (52, 72)
Kosi Zonal 63 56 (43, 67) 90 34 (25, 45)
Nepalganj Medical College 75 49 (38, 60) 106 28 (21, 38)
Western Regional 43 65 (50, 78) 53 43 (31, 57)
Prior OPV doses <0.001 0.007
0 122 75 (66, 81) 137 49 (41, 57)
1 112 59 (50, 69) 156 48 (40, 56)
2 86 46 (36, 57) 152 33 (26, 41)
Breastfeeding 0.672 0.536
Exclusive 265 62 (56, 68) 361 44 (39, 50)
Some 51 57 (43, 70) 80 38 (28, 48)
None or don’t know 4 75 (30, 99) 4 50 (15, 85)
Stunting 0.567 0.757
Severe 32 56 (39, 72) 47 40 (28, 55)
Moderate, mild or normal 288 62 (56, 68) 398 44 (39, 48)
Wasting 0.381 0.885
Severe 38 68 (52, 81) 55 42 (30, 55)
Moderate, mild or normal 282 61 (55, 66) 390 43 (38, 48)
Lifetime number prior episodes of diarrhea 0.700 1.000
0–2 289 62 (56, 67) 400 43 (38, 48)
3+ 31 58 (41, 74) 45 42 (29, 57)
a

Wilson score confidence interval.

b

Two-tailed Fisher’s exact test.